01492nas a2200265   4500000000100000008004100001260001300042653003100055653002000086653004200106653001900148653001100167653001200178653001700190100001300207700001300220700001600233245009900249856005900348300001000407490000700417050001400424520077400438022001401212       2004                            d  c2004 Nov10aAfrica South of the Sahara10aAnti-HIV Agents10aAntiretroviral Therapy, Highly Active10aHIV Infections10aHumans10aleprosy10aTuberculosis1 aReid S E1 aReid C A1 aVermund S H00aAntiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy.  uhttp://std.sagepub.com/content/15/11/713.full.pdf+html  a713-60 v15  aREID 20043 a<p>Declining drug costs and increases in international donor interest are leading to greater availability of antiretroviral treatment programmes for persons living with the human immunodeficiency virus in parts of sub-Saharan Africa. Ensuring adequate adherence to antiretroviral drug therapy is one of the principal challenges facing successful implementation in Africa, where 70% of the world's infected persons live. Tuberculosis and leprosy are two diseases of global importance whose control programmes can provide important lessons for developing antiretroviral drug adherence strategies. This paper examines various approaches used in tuberculosis and leprosy control which could help enhance adherence to antiretroviral therapy in resource-limited settings.</p>  a0956-4624